A lab study published last week found that vaccinated people who were infected with Omicron, a COVID-19 variant, had high levels of antibodies that would probably protect against BA.2. If […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/05/nyt.png400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2022-03-19 09:47:462022-03-22 09:49:16Another Covid Surge May Be Coming. Are We Ready for It?
This week, Pfizer and Moderna asked the FDA to authorize fourth doses of their vaccines. Meanwhile, a new study shows protection from one J&J shot lasts at least six months. […]
While the number of cases of the Omicron variant has been decreasing over the past few weeks, health officials are concerned about the BA.2 variant, which appears to be more […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2022/02/WBZ-Radio-news.jpg400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2022-02-24 09:58:532022-02-28 10:09:06New Studies Shed Light On The Severity And Transmissibility Of BA.2 Variant
While the rise of another strain has some Americans stressed over the prospect of yet another wave of cases, it may not be time to panic just yet. Read Article
https://cvvr.hms.harvard.edu/wp-content/uploads/2022/02/NY-Mag.png400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2022-02-19 09:33:302022-02-21 09:35:31How Worried Should We Be About the BA.2 Omicron Subvariant?
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/05/nyt.png400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2022-02-04 08:59:412022-02-15 09:01:40Younger Americans Benefited Less From Booster Shots Than Older People
https://cvvr.hms.harvard.edu/wp-content/uploads/2022/01/sciam.png400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2022-01-14 13:07:342022-01-14 13:07:34What’s Holding Up New Omicron Vaccines?
Two reports released Thursday show that people who get booster doses of Johnson & Johnson’s Janssen vaccine are well protected against severe disease and hospitalization from the Omicron variant of […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/04/CNN.png400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-12-30 11:34:222021-12-30 11:34:22Studies indicate J&J Covid-19 vaccine booster protects people against severe illness from Omicron variant
After the vaccine received emergency use authorization this year, he turned to the Provincetown outbreak and Omicron. Plus, recognizing the unsung heroes of vaccine production. Read Article
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/04/Boston-globe.jpg240240Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-12-15 10:59:002021-12-16 11:00:35414 days at work, zero days off: Dan Barouch and the race to develop the Johnson & Johnson vaccine
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/04/Boston-globe.jpg240240Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-12-02 19:44:282021-12-02 19:44:28‘I don’t think we’re back to square one.’ Beth Israel races to find out how much vaccines protect against Omicron
Another Covid Surge May Be Coming. Are We Ready for It?
/in NewsA lab study published last week found that vaccinated people who were infected with Omicron, a COVID-19 variant, had high levels of antibodies that would probably protect against BA.2. If […]
As picture of Covid vaccine durability gets clearer, J&J makes a strong showing
/in NewsThis week, Pfizer and Moderna asked the FDA to authorize fourth doses of their vaccines. Meanwhile, a new study shows protection from one J&J shot lasts at least six months. […]
New Studies Shed Light On The Severity And Transmissibility Of BA.2 Variant
/in NewsWhile the number of cases of the Omicron variant has been decreasing over the past few weeks, health officials are concerned about the BA.2 variant, which appears to be more […]
How Worried Should We Be About the BA.2 Omicron Subvariant?
/in NewsWhile the rise of another strain has some Americans stressed over the prospect of yet another wave of cases, it may not be time to panic just yet. Read Article
New Covid Variants Complicate the Question of Vaccine Mandates
/in NewsOfficials mulling new pandemic policies need to know how quickly vaccine protection wanes. But scientists don’t have a clear answer. Read Article
Younger Americans Benefited Less From Booster Shots Than Older People
/in NewsAmong those under age 50, vaccination even without a booster protected strongly against hospitalization and death.. Read Article
What’s Holding Up New Omicron Vaccines?
/in NewsVaccine makers worry yet another variant will start dominating in the months it takes to roll out shots against this one. Read Article
Studies indicate J&J Covid-19 vaccine booster protects people against severe illness from Omicron variant
/in NewsTwo reports released Thursday show that people who get booster doses of Johnson & Johnson’s Janssen vaccine are well protected against severe disease and hospitalization from the Omicron variant of […]
414 days at work, zero days off: Dan Barouch and the race to develop the Johnson & Johnson vaccine
/in NewsAfter the vaccine received emergency use authorization this year, he turned to the Provincetown outbreak and Omicron. Plus, recognizing the unsung heroes of vaccine production. Read Article
‘I don’t think we’re back to square one.’ Beth Israel races to find out how much vaccines protect against Omicron
/in NewsThe hospital’s researchers are part of a global effort to understand the fast-spreading variant. Read Article